Medicare News and Research

RSS

Some House GOP lawmakers threatening to walk away from last year's budget pact

Conservative Republicans are seeking deeper cuts in both discretionary and mandatory spending. The White House and Democratic lawmakers are "crying foul" and some GOP veterans caution it could produce gridlock. In the background, three key departures from the Senate Finance Committee could make that panel, which oversees Medicare and much of the health law, less centrist.

9 Mar 2012

Viewpoints: Wilensky on bipartisan Medicare reform; Mass. 2006 health law and 2012 GOP politics; Reinstating advanced care planning

The Super Tuesday exit polls yielded a mountain of data in 10 states, but the most telling single statistic may have been in Massachusetts, which Mitt Romney won in a largely uncontested rout. Yet believe it or not, he still lost on health care. The exit poll asked voters their opinion of the "Massachusetts Health Care Law," with the options of Did Not Go Far Enough, About Right and Went Too Far. Remarkably, 51% said the bill went too far, while only 37% said it was about right, and 6% said not far enough.

9 Mar 2012

U.S. Physical Therapy fourth quarter net revenues increase 13.8% to $60,678,000

U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics, today reported results for the fourth quarter and year ended December 31, 2011.

9 Mar 2012

FDA approves Teva's ProAir HFA with dose counter for asthma, COPD and EIB

Teva Respiratory announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA with a dose counter for use in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

8 Mar 2012

Tavenner: Final exchange rule release just weeks away

Modern Healthcare and CQ HealthBeat report that the final rule on health insurance exchanges will be out "very soon."

8 Mar 2012

Young adults, school health centers and cost-cutting: Examining elements of the health law's implementation

News outlets report on various provisions of the health law and their impact on the marketplace and access to care.

8 Mar 2012

Lilly, Boehringer Ingelheim announce availability of Jentadueto tablets

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Jentadueto (linagliptin/metformin hydrochloride) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S.

8 Mar 2012

First Edition: March 7, 2012

Reporting for Kaiser Health News in collaboration with The Washington Post, Susan Jaffe writes: "In the latest effort to enlist seniors in the fight against Medicare fraud, federal officials have overhauled Medicare billing statements to make it easier to find bogus charges without a magnifying glass."

7 Mar 2012

GOP lawmakers face strategic fits and starts in health law repeal efforts

Meanwhile, as some House Republicans push to undo the measure's cost-cutting panel, known as the Independent Payment Advisory Board, its advocates are springing to its defense.

7 Mar 2012

Drugmakers paid out $8 billion in Medicare and Medicaid fraud fines in 10 years

The nation's largest drugmakers have paid at least $8 billion in fines for repeatedly defrauding Medicare and Medicaid over the past decade, but they remain in business with the federal government because they are often the sole suppliers of critical products, records show.

7 Mar 2012

Quality data has little impact on mortality rates

Research published in the latest issue of Health Affairs concluded that the performance data published on the Hospital Compare website did not result in fewer patient deaths.

7 Mar 2012

Only about 75% of U.S. HIV/AIDS patients remain in care consistently

Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online this week in AIDS. The study of patients across the United States is the first to provide a comprehensive national estimate of HIV care retention and information about patients who are most likely to continue their treatment over time.

7 Mar 2012

States cut birth control subsidies; Impact of abortion laws hard to ascertain

Reuters reports that states are cutting birth control subsidies while The Associated Press writes that it's difficult to gauge what impact anti-abortion laws have on reducing the procedure. The Arizona House gave initial approval to blocking abortion providers from getting federal funding for family planning services through the state. A similar move in Texas, which is now in effect, reverberates.

6 Mar 2012

AMA details concerns about payment policy changes for Medicare Part C, D

Modern Healthcare details the positions taken by the American Medical Association in response to recent changes proposed by the Centers for Medicare & Medicaid Services. Also, in related news, a new panel sets to work on improving the physician payment system.

6 Mar 2012

RAND researchers outline methods to improve creation of health care performance reports

As health care reform expands the use of "report cards" to grade health care providers, greater attention to reporting methods may be needed to assure the quality of such efforts, according to a new RAND Corporation study.

6 Mar 2012

State news: Ore. Gov. signs reform bill; Texas seeks early release of sick inmates

If Oregon's Democratic governor is right, the bill he signed Friday will improve health care and reduce costs so significantly that it could help fix the federal budget. The Obama administration is watching with keen interest - and so are critics who say Gov. John Kitzhaber's plan is just another example of government overreach.

6 Mar 2012

Viewpoints: Statins and diabetes; Frightening tobacco warnings; The U.S. dental crisis

We're overdosing on cholesterol-lowering statins, and the consequence could be a sharp increase in the incidence of Type 2 diabetes. This past week, the Food and Drug Administration raised questions about the side effects of these drugs and developed new labels for these medications that will now warn of the risk of diabetes and memory loss.

6 Mar 2012

Cost estimates for health law's subsidies boosted by $111 billion

The new estimate, which represents an estimated 30 percent jump for an eight-year period, triggered calls during hearings last week by key House Republicans for the Obama administration to explain the number.

6 Mar 2012

AMAG fourth quarter total revenues decrease to $14.9 million

AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2011. As of December 31, 2011, the company's cash, cash equivalents and investments totaled approximately $230 million.

5 Mar 2012